Your browser doesn't support javascript.
loading
Formulation of Dronedarone Hydrochloride-Loaded Proliposomes: In Vitro and In Vivo Evaluation Using Caco-2 and Rat Model.
Kovvasu, Surya Prakasarao; Kunamaneni, Priyanka; Yeung, Steven; Rueda, Javier; Betageri, Guru V.
Afiliación
  • Kovvasu SP; College of Pharmacy, Western University of Health Sciences, Pomona, California, 91766, USA.
  • Kunamaneni P; College of Pharmacy, Western University of Health Sciences, Pomona, California, 91766, USA.
  • Yeung S; College of Pharmacy, Western University of Health Sciences, Pomona, California, 91766, USA.
  • Rueda J; College of Pharmacy, Western University of Health Sciences, Pomona, California, 91766, USA.
  • Betageri GV; College of Pharmacy, Western University of Health Sciences, Pomona, California, 91766, USA. gbetageri@westernu.edu.
AAPS PharmSciTech ; 20(6): 226, 2019 Jun 18.
Article en En | MEDLINE | ID: mdl-31214813
ABSTRACT
The objective of the present study was to develop a proliposomal formulation to increase the oral bioavailability of dronedarone hydrochloride (dronedarone HCl) by enhancing solubility, dissolution, and/or intestinal absorption. Proliposomes were prepared by using solvent evaporation method. In this process, different ratios of drug, phospholipids, such as soy phosphatidylcholine (SPC), Phospholipon 90H, hydrogenated egg phosphatidylcholine (HEPC), and dimyristoyl phosphatidylglycerol (DMPG), and cholesterol were used. Physical characterization and in vitro dissolution studies were evaluated for the prepared formulations. In vitro transport across the membrane was carried out using Caco-2 cells. Among all the formulations, the amount of drug released in dissolution was higher with DPF8 formulation (drugDMPG Nacholesterol120.2) compared to the pure drug. Also, Caco-2 cell permeability studies resulted in 2.6-fold increase in apparent permeability. Optimized formulation was evaluated in vivo in male Sprague-Dawley rats. After single oral administration of optimized formulation (DPF8), a relative bioavailability of 148.36% was achieved compared to the pure drug. Improved oral bioavailability of dronedarone could be provided by an optimized proliposomal formulation with enhanced solubility, permeability, and oral absorption.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Dronedarona / Liposomas / Antiarrítmicos Límite: Animals / Humans / Male Idioma: En Revista: AAPS PharmSciTech Asunto de la revista: FARMACOLOGIA Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Dronedarona / Liposomas / Antiarrítmicos Límite: Animals / Humans / Male Idioma: En Revista: AAPS PharmSciTech Asunto de la revista: FARMACOLOGIA Año: 2019 Tipo del documento: Article País de afiliación: Estados Unidos
...